康臣药业建议采纳股份奖励计划

Core Viewpoint - 康臣药业 (01681) has proposed a share award plan to incentivize and reward individuals contributing to the group's growth and development, with the board's decision made on November 6, 2025 [1] Summary by Relevant Categories - Company Initiatives - The board of 康臣药业 has resolved to adopt a share award plan as part of its strategy to motivate participants involved in the company's growth [1]